Medicare Enrolled
Dr. Michael Zaboski, M.D.
Emergency Medicine · Elizabeth, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zaboski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zaboski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zaboski
Dr. Michael Zaboski is an emergency medicine specialist in Elizabeth, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Zaboski performed 1,828 Medicare services across 1,239 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zaboski received a total of $17,119 from 49 pharmaceutical and/or device companies across 914 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in emergency medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zaboski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in NJ
$17,119 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,828
Medicare services
Top 3% in NJ for emergency medicine
1,239
Unique beneficiaries
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~96 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
272 | $62 | $80 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
204 | $83 | $122 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
181 | $53 | $83 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
120 | $10 | $20 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
120 | $130 | $134 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
120 | $44 | $71 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
108 | $84 | $86 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
82 | $120 | $163 |
| Home visit, established patient, high complexity A home visit for an established patient involving high-level medical decision making, lasting at least 60 minutes. |
81 | $143 | $195 |
| Skin and tissue removal, 20 sq cm or less This procedure involves the surgical excision of skin and underlying tissue from an area measuring 20 square centimeters or smaller. |
79 | $50 | $155 |
| Ultrasound of arm and leg arteries This procedure uses sound waves to create images of the blood vessels in the arms and legs. It allows healthcare providers to examine the structure and blood flow within these arteries. |
77 | $66 | $109 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
65 | $106 | $151 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
63 | $63 | $81 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
56 | $34 | $40 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
44 | $26 | $27 |
| Emergency department visit, high complexity An emergency department visit involving a high level of medical decision making. |
38 | $149 | $1,526 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
34 | $32 | $72 |
| Emergency department visit, moderate complexity An emergency department visit for an established or new patient involving a moderate level of medical decision making. |
32 | $93 | $1,048 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
22 | $34 | $40 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
18 | $283 | $290 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
12 | $183 | $1,960 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$17,119
Total received (2018-2024)
Avg $2,446/year across 7 years
Top 1% in NJ for emergency medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
914
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,126 (76.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,981 (23.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,057
2023
$3,019
2022
$502
2021
$209
2020
$1,190
2019
$6,312
2018
$2,831
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$363
ABBVIE INC.
$357
Novo Nordisk Inc
$334
Exact Sciences Corporation
$321
Lilly USA, LLC
$288
PFIZER INC.
$244
GlaxoSmithKline, LLC.
$225
Bayer Healthcare Pharmaceuticals Inc.
$190
Novartis Pharmaceuticals Corporation
$103
Boehringer Ingelheim Pharmaceuticals, Inc.
$93
Abbott Laboratories
$78
Janssen Pharmaceuticals, Inc
$75
Azurity Pharmaceuticals, Inc.
$71
Amgen Inc.
$62
Ardelyx, Inc.
$52
Currax Pharmaceuticals LLC
$42
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
Gilead Sciences, Inc.
$30
Otsuka America Pharmaceutical, Inc.
$21
Merck Sharp & Dohme LLC
$17
Esperion Therapeutics, Inc.
$16
Mannkind Corporation
$15
SCILEX PHARMACEUTICALS INC.
$14
CashFlow Solutions, LLC
$14
Top 3 companies account for 34.5% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$5,090
Novo Nordisk Inc
$1,708
GlaxoSmithKline, LLC.
$1,169
Lilly USA, LLC
$1,055
AstraZeneca Pharmaceuticals LP
$980
Boehringer Ingelheim Pharmaceuticals, Inc.
$678
Exact Sciences Corporation
$591
Amgen Inc.
$512
Janssen Pharmaceuticals, Inc
$497
Bayer Healthcare Pharmaceuticals Inc.
$443
ABBVIE INC.
$440
Amarin Pharma Inc.
$398
Merck Sharp & Dohme Corporation
$317
AbbVie Inc.
$314
Novartis Pharmaceuticals Corporation
$281
Abbott Laboratories
$278
SANOFI-AVENTIS U.S. LLC
$270
ARBOR PHARMACEUTICALS, INC.
$220
Azurity Pharmaceuticals, Inc.
$203
Kowa Pharmaceuticals America, Inc.
$197
Takeda Pharmaceuticals U.S.A., Inc.
$179
Allergan Inc.
$170
Gilead Sciences, Inc.
$167
Allergan, Inc.
$152
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$119
Ardelyx, Inc.
$96
OptiNose US, Inc.
$69
Merck Sharp & Dohme LLC
$63
Scilex Pharmaceuticals Inc.
$62
Dexcom, Inc.
$43
Currax Pharmaceuticals LLC
$42
MannKind Corporation
$32
West-Ward Pharmaceuticals
$27
Aytu BioScience, Inc
$27
SCILEX PHARMACEUTICALS INC.
$25
Astellas Pharma US Inc
$25
Otsuka America Pharmaceutical, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$19
Esperion Therapeutics, Inc.
$16
Teva Pharmaceuticals USA, Inc.
$15
Horizon Therapeutics plc
$15
Orexo US, Inc.
$15
Mannkind Corporation
$15
Arbor Pharmaceuticals, Inc.
$14
CashFlow Solutions, LLC
$14
Nestle HealthCare Nutrition Inc.
$13
Supernus Pharmaceuticals, Inc.
$13
Eisai Inc.
$12
Kerecis Limited
$2
Top 3 companies account for 46.5% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · AFREZZA · AIRSUPRA · AJOVY · AMYVID · ANORO · AREXVY · Aimovig · Amitiza · BASAGLAR · BELSOMRA · BREO · BREZTRI · BYDUREON · BYSTOLIC · Belviq · Bidil · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · CONTRAVE · Cologuard Collection Kit · Dexcom G6 Transmitter · EDARBYCLOR · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Edarbi · Edarbyclor · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · IBSRELA · INVOKANA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerecis Omega3 Wound · Kerendia · LEQVIO · LINZESS · LYMPHA PRESS OPTIMAL PLUS(US) BT · LYRICA · Levemir · Livalo · MAVYRET · MOUNJARO · Mitigare · NEXLETOL · NUCALA · NURTEC ODT · Natesto · Otezla · Ozempic · PAXLOVID · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · REXULTI · Repatha · Rybelsus · SEGLENTIS · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Saxenda · TOUJEO · TRELEGY ELLIPTA · TROKENDI XR · TRULICITY · TRUMENBA · Tresiba · Trintellix · UBRELVY · VERQUVO · VESICARE · VIBERZI · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · Xhance · ZENPEP · ZTLido · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for emergency medicine in NJ.
Geographic Context
Emergency medicines within 10 mi
3,058
Per 100K population
534.1
County median income
$100,117
Nearest hospital
NEWARK BETH ISRAEL MEDICAL CENTER
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zaboski is a clinical cardiology specialist, with above-average Medicare volume (top 3% in NJ), with low-engagement industry engagement in the top 1% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zaboski experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Zaboski performed 272 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zaboski receive payments from pharmaceutical companies?
Yes. Dr. Zaboski received a total of $17,119 from 49 companies across 914 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zaboski's costs compare to other emergency medicines in Elizabeth?
Dr. Zaboski's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zaboski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Emergency Medicines in Elizabeth
Browse emergency medicines in Elizabeth ranked by procedure volume and transparency data.
Highest volume
Top Emergency Medicines in NJ
Emergency medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Emergency Medicines in NJ
Which NJ emergency medicines receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology